Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
08/13/2009 | WO2009097998A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
08/13/2009 | WO2009051660A3 Compounds for activating tgf-beta signaling |
08/13/2009 | WO2009041705A9 5-membered heterocyclic compounds as proton pump inhibitors |
08/13/2009 | WO2009024341A3 Condensed anthran i lami de derivatives as insectisides |
08/13/2009 | US20090203866 Novel Polymers |
08/13/2009 | US20090203710 Novel piperidine derivative |
08/13/2009 | US20090203702 INHIBITORS OF p38 |
08/13/2009 | CA2714480A1 3,8-diaminotetrahydroquinoline derivative |
08/12/2009 | EP2088141A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
08/12/2009 | EP2086967A2 Inhibitors of hepatitis c virus |
08/12/2009 | EP2086966A1 2-carboxy thiophene derivatives as anti viral agents |
08/12/2009 | EP2086960A1 Novel inhibitors of glutaminyl cyclase |
08/12/2009 | EP2086947A1 Pyrimidines and their use as cxcr2 receptor antagonists |
08/12/2009 | EP2086943A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
08/12/2009 | EP2086942A2 Novel compounds |
08/12/2009 | EP2086935A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
08/12/2009 | EP1756096B1 Indolyl derivatives as liver-x-receptor modulators |
08/12/2009 | CN101506224A Peptide epoxyketones for proteasome inhibition |
08/12/2009 | CN101506195A New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds |
08/12/2009 | CN101506194A New pyridine analogues |
08/12/2009 | CN101506165A Phenyl, pyridine and quinoline derivatives |
08/12/2009 | CN101505803A Composition for diagnosing amyloid-related disease |
08/12/2009 | CN101503402A 2-aniline pyrimidine derivative, as well as preparation and uses thereof |
08/12/2009 | CN101503398A Novel sulfide or sulfone containing dianhydride, and preparation and use thereof |
08/12/2009 | CN100526323C 铑和铱的络合物 Complexes of rhodium and iridium |
08/12/2009 | CN100526310C Cyclopropyl-thienyl-carboxamide as fungicides |
08/12/2009 | CN100526307C Metalloproteinase inhibitors |
08/11/2009 | US7572915 Quinoline derivatives as phosphodiesterase inhibitors |
08/11/2009 | US7572914 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
08/11/2009 | US7572826 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
08/11/2009 | US7572806 PPAR active compounds |
08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
08/11/2009 | US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
08/11/2009 | US7572753 Tetrazole fungicides |
08/11/2009 | CA2546660C Selective inhibitors of viral or bacterial neuraminidase |
08/11/2009 | CA2527933C Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
08/11/2009 | CA2395846C Diazepan derivatives or salts thereof |
08/06/2009 | WO2009097401A1 2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE) |
08/06/2009 | WO2009097306A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity |
08/06/2009 | WO2009097223A1 Substituted gamma lactams as therapeutic agents |
08/06/2009 | WO2009096455A1 Pharmaceutical composition for treatment of fatty liver diseases |
08/06/2009 | WO2009096202A1 Halogenated polycyclic aromatic compound and method for producing the same |
08/06/2009 | WO2009096080A1 Piperidine derivative |
08/06/2009 | WO2009095726A1 Acrylamide derivatives as vanilloid receptor 1 modulators |
08/06/2009 | WO2009095399A2 Pyrazine derivatives and their use as protein kinase inhbitors |
08/06/2009 | WO2009095163A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
08/06/2009 | WO2009054952A3 Small molecule inhibitors of parp activity |
08/06/2009 | US20090197925 O-cyclopropyl-carboxanilides and their use |
08/06/2009 | US20090197901 Variolin derivatives and their use as antitumor agents |
08/06/2009 | CA2714008A1 2-amino quinoline derivatives useful as inhibitors of .beta.-secretase (bace) |
08/06/2009 | CA2713553A1 Pyrazine derivatives and their use as protein kinase inhibitors |
08/06/2009 | CA2713293A1 Piperidine derivative |
08/06/2009 | CA2713043A1 Substituted gamma lactams as therapeutic agents |
08/06/2009 | CA2712885A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity |
08/06/2009 | CA2712854A1 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
08/06/2009 | CA2711673A1 Pharmaceutical compositions for treating fatty liver disease |
08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
08/05/2009 | EP2085383A1 Piperidine derivatives or salts thereof |
08/05/2009 | EP2084148A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
08/05/2009 | EP2084140A1 Arginine derivatives with np-i antagonistic activity |
08/05/2009 | EP2083826A2 Pyrimidine derivatives as posh and posh-ap inhibitors |
08/05/2009 | EP1984354B1 Pesticides containing a bicyclic bisamide structure |
08/05/2009 | EP1924560B1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
08/05/2009 | EP1877398B1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
08/05/2009 | EP1753721B1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
08/05/2009 | EP1699454B1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
08/05/2009 | EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
08/05/2009 | EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
08/05/2009 | EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection |
08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
08/05/2009 | EP1341786B9 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
08/05/2009 | EP1296974B1 2-cyanopyrrolidine derivatives and their use as medicaments |
08/05/2009 | CN101501027A Thiophene-sulfonic acid picolyl amides |
08/05/2009 | CN101501026A Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof |
08/05/2009 | CN101501025A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
08/05/2009 | CN101501008A Arylpiperazine derivatives and uses thereof |
08/05/2009 | CN101501007A Quinazoline derivative |
08/05/2009 | CN101500995A 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
08/05/2009 | CN101497600A 2,4,5- tri-substituted-1,3-dithiolane, synthesizing method and use thereof |
08/05/2009 | CN101497593A 5-hydroxy coumarin and pyranoid type coumarin compounds, synthesizing method and use |
08/05/2009 | CN101497426A Method for preparing tetrathiafulvalene molecule-based micrometre and/or nano functional material |
08/05/2009 | CN100522958C Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates |
08/05/2009 | CN100522955C Cytotoxic agents containing novel potent taxanes and their therapeutic use |
08/05/2009 | CN100522949C Piperazinedione compounds |
08/05/2009 | CN100522947C CCK-1 receptor modulators |
08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
08/04/2009 | US7569704 Dye compound |
08/04/2009 | US7569598 Isomerization; crystallization |
08/04/2009 | US7569596 e.g. N1-[(E)-1-(4-fluorophenyl)methylidene]-4-(1,3-thiazol-2-yl)-1H-1,2-imidazolediamine; anticarcinogenic agent; sid effect reduction |
08/04/2009 | US7569595 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
08/04/2009 | US7569584 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |